1,1,1,3,3,3-Hexafluoropropan-2-yl 4-[[2-(1,3,3a,4,6,6a-hexahydrofuro[3,4-c]pyrrol-5-yl)-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate

InChIKey	`KOPDPPBFKXJXGN-UHFFFAOYSA-N`
Compound Name	1,1,1,3,3,3-Hexafluoropropan-2-yl 4-[[2-(1,3,3a,4,6,6a-hexahydrofuro[3,4-c]pyrrol-5-yl)-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate
Canonical SMILES	`O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2ccc(C(F)(F)F)cc2N2CC3COCC3C2)CC1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Cross-Family
Avg pChEMBL	7.35
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q99685	MGLL	Homo sapiens	Human	PF12146	8.7	IC50	ChEMBL;BindingDB
Q13093	PLA2G7	Homo sapiens	Human	PF03403	6.0	IC50	ChEMBL;BindingDB